AZD4547 Options

[86] claimed that RG7834, a novel oral HBV gene expression inhibitor, could reduce the levels of viral proteins and decrease viremia. RG7834 is a little-molecule compound belonging to the dihydroquinolizinones chemical course comparable to RNAi but through a special mechanism. Together with its n
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15